| 1 |
19733607 | Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. | 2009 Nov 13 |
1 |
| 2 |
15671203 | Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects. | 2005 May |
2 |
| 3 |
15801935 | Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. | 2005 Apr |
1 |
| 4 |
1347659 | Biochemical effects of high single doses of moclobemide in man: correlation with plasma concentrations. | 1992 |
1 |
| 5 |
1646924 | Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. | 1991 |
3 |
| 6 |
2250565 | Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers. | 1990 |
1 |
| 7 |
2469451 | Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers. | 1989 Feb |
1 |
| 8 |
2817346 | Detection of 3,4-dihydroxyphenylglycolaldehyde in human brain by high-performance liquid chromatography. | 1989 Jul |
1 |